Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Yakushiji

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2005
[Combination chemotherapy with oral TS-1 and low-dose CPT-11 by hepatic arterial infusion for multiple hepatic metastases from colon cancer--a case report]Masatsugu Hiraki, Hiroyuki Yakushiji, Kazuyoshi Hashiguchi, et al.
Journal of Surgical Oncology|March 6, 2003
Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinomaShiroh Matsukura, Kohji Miyazaki, Hiroyuki Yakushiji, et al.
Nucleic Acids Research. Supplement (2001)|August 9, 2003
Substrate recognition by the human MTH1 proteinHiroyuki Kamiya, Laurence Dugué, Hiroyuki Yakushiji, et al.
Journal of Molecular Biology|April 21, 2004
Probing the substrate recognition mechanism of the human MTH1 protein by nucleotide analogsHiroyuki Kamiya, Hiroyuki Yakushiji, Laurence Dugué, et al.
Cancer Research|October 6, 2005
Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branchingT J Bowen, Hiroyuki Yakushiji, Cristina Montagna, et al.
FEBS Letters|February 20, 2002
8-Chloro-dGTP, a hypochlorous acid-modified nucleotide, is hydrolyzed by hMTH1, the human MutT homologKatsuyoshi Fujikawa, Hiroyuki Yakushiji, Yusaku Nakabeppu, et al.
Human Molecular Genetics|May 13, 2005
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressorLaura Erker, Ralf Schubert, Hiroyuki Yakushiji, et al.
Annals of Surgical Oncology|May 3, 2002
Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinomaNaohiko Kohya, Kohji Miyazaki, Shiroh Matsukura, et al.
Human Molecular Genetics|June 24, 2004
Cancer chemoprevention by the antioxidant tempol in Atm-deficient miceRalf Schubert, Laura Erker, Carrolee Barlow, et al.
Journal of Biochemistry|October 31, 2006
Recognition of nucleotide analogs containing the 7,8-dihydro-8-oxo structure by the human MTH1 proteinHiroyuki Kamiya, Claudio Cadena-Amaro, Laurence Dugué, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 28, 2005
[Combination chemotherapy with oral TS-1 and low-dose CPT-11 by hepatic arterial infusion for multiple hepatic metastases from colon cancer--a case report]Masatsugu Hiraki, Hiroyuki Yakushiji, Kazuyoshi Hashiguchi, et al.
Journal of Surgical Oncology|March 6, 2003
Combined loss of expression of O6-methylguanine-DNA methyltransferase and hMLH1 accelerates progression of hepatocellular carcinomaShiroh Matsukura, Kohji Miyazaki, Hiroyuki Yakushiji, et al.
Nucleic Acids Research. Supplement (2001)|August 9, 2003
Substrate recognition by the human MTH1 proteinHiroyuki Kamiya, Laurence Dugué, Hiroyuki Yakushiji, et al.
Journal of Molecular Biology|April 21, 2004
Probing the substrate recognition mechanism of the human MTH1 protein by nucleotide analogsHiroyuki Kamiya, Hiroyuki Yakushiji, Laurence Dugué, et al.
Cancer Research|October 6, 2005
Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branchingT J Bowen, Hiroyuki Yakushiji, Cristina Montagna, et al.
FEBS Letters|February 20, 2002
8-Chloro-dGTP, a hypochlorous acid-modified nucleotide, is hydrolyzed by hMTH1, the human MutT homologKatsuyoshi Fujikawa, Hiroyuki Yakushiji, Yusaku Nakabeppu, et al.
Human Molecular Genetics|May 13, 2005
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressorLaura Erker, Ralf Schubert, Hiroyuki Yakushiji, et al.
Annals of Surgical Oncology|May 3, 2002
Deficient expression of O(6)-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and hMSH2 is related to poor prognosis in human biliary tract carcinomaNaohiko Kohya, Kohji Miyazaki, Shiroh Matsukura, et al.
Human Molecular Genetics|June 24, 2004
Cancer chemoprevention by the antioxidant tempol in Atm-deficient miceRalf Schubert, Laura Erker, Carrolee Barlow, et al.
Journal of Biochemistry|October 31, 2006
Recognition of nucleotide analogs containing the 7,8-dihydro-8-oxo structure by the human MTH1 proteinHiroyuki Kamiya, Claudio Cadena-Amaro, Laurence Dugué, et al.
Pageof 2